Highlight Therapeutics, S.L.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Highlight Therapeutics, S.L. - overview
Location
Valencia, -, Spain
Primary Industry
Biotechnology
About
Based in Valencia, Spain, Highlight Therapeutics S. L. , is a biopharmaceutical company focused on developing therapies for dermato-oncology, primarily targeting skin cancers through advanced RNA-based treatments. In September 2025, Highlight Therapeutics, S.
L. raised EUR 15 million in venture funding led by new investor Buenavista Equity Partners. The company will use the funding to accelerate its clinical trial testing.
Current Investors
DCN Ventures, Advent Life Sciences, Columbus Venture Partners
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment
Website
www.highlighttherapeutics.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.